FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2060273223> ?p ?o ?g. }

• W2060273223 endingPage "239" @default.
• W2060273223 startingPage "233" @default.
• W2060273223 abstract "In the present study, DNA flow cytometry (FCM) and immunocytochemistry (ICC) with a selected panel of antibodies were performed on 51 cases of malignant tumors which were referred for fine-needle aspiration biopsy (FNAB) to our Department of Cytology for the last 2 yr. Twelve cases were diagnosed as neuroblastoma, 16 as Ewing's sarcoma, 2 as retinoblastoma, 5 as non-Hodgkin's lymphoma (NHL), 5 as rhabdomyosarcoma, 2 as peripheral neuroectodermal tumors (PNETs), and 8 as Wilms' tumor. Eleven of 12 neuroblastomas were diploid by FCM, and 1 was aneuploid, with an S-phase fraction (SPF) of 8.3%. Neuron-specific enolase (NSE) was negative in 3 and positive in 8 cases of neuroblastoma, whereas neuroblastoma marker was positive in 3/11. Sixteen of 17 Ewing's sarcomas were diploid, and 1 showed tetraploid aneuploidy, with an SPF of 10.06%. Eight of 13 Ewing's sarcomas were positive for Mic-2 gene product (Ewing's marker). All 5 NHL were positive for leukocyte-common antigen (LCA). Three of 5 rhabdomyosarcomas were diploid, and 2 cases showed aneuploidy. Rhabdomyosarcoma showed muscle-specific actin positivity in 4 and desmin positivity in 3 cases. All 3 cases of PNET were diploid and positive for the Mic-2 gene product, whereas NSE and vimentin were positive in 2 cases. Both cases of retinoblastoma were diploid. Immunostaining was noncontributory in 1 case, and the other showed positivity for the retinoblastoma gene product, NSE, and chromogranin. Seven of 8 Wilms' tumors were diploid, and 1 showed aneuploid, with an SPF of 11.13%. Seven of 8 Wilms' tumors were positive for cytokeratin (CK), 5 were positive for NSE, 6 were positive for epithelial membrane antigen (EMA), and 5 were positive for vimentin. FNAB diagnosis of malignant round-cell tumors is difficult only by light microscopy. Due to the availability of specific markers for subgrouping tumors, ICC has proved to be more useful these days, while DNA FCM has little diagnostic value, as most of them are diploid. Further ancillary studies, e.g., electron microscopy, image analysis, and other molecular investigations, are required to further categorize these tumors more precisely for better clinical management of these cases. Diagn. Cytopathol. 24:233–239, 2001. © 2001 Wiley-Liss, Inc." @default.
• W2060273223 created "2016-06-24" @default.
• W2060273223 creator A5010130353 @default.
• W2060273223 creator A5032635453 @default.
• W2060273223 creator A5038762203 @default.
• W2060273223 creator A5049526464 @default.
• W2060273223 creator A5054566593 @default.
• W2060273223 creator A5057657554 @default.
• W2060273223 creator A5071257048 @default.
• W2060273223 date "2001-01-01" @default.
• W2060273223 modified "2023-09-26" @default.
• W2060273223 title "Role of immunocytochemistry and DNA flow cytometry in the fine-needle aspiration diagnosis of malignant small round-cell tumors" @default.
• W2060273223 cites W1963957597 @default.
• W2060273223 cites W1974148205 @default.
• W2060273223 cites W1980351350 @default.
• W2060273223 cites W2009706415 @default.
• W2060273223 cites W2010166401 @default.
• W2060273223 cites W2014616446 @default.
• W2060273223 cites W2022345902 @default.
• W2060273223 cites W2026874587 @default.
• W2060273223 cites W2028107173 @default.
• W2060273223 cites W2028805628 @default.
• W2060273223 cites W2066353992 @default.
• W2060273223 cites W2066946290 @default.
• W2060273223 cites W2070927720 @default.
• W2060273223 cites W2079570691 @default.
• W2060273223 cites W2081591980 @default.
• W2060273223 cites W2087373698 @default.
• W2060273223 cites W2091422759 @default.
• W2060273223 cites W2094774628 @default.
• W2060273223 cites W2096457660 @default.
• W2060273223 cites W2123898517 @default.
• W2060273223 cites W2142919011 @default.
• W2060273223 cites W2154106562 @default.
• W2060273223 cites W2169790726 @default.
• W2060273223 cites W2323235006 @default.
• W2060273223 cites W2335449765 @default.
• W2060273223 doi "https://doi.org/10.1002/dc.1050" @default.
• W2060273223 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11285617" @default.
• W2060273223 hasPublicationYear "2001" @default.
• W2060273223 type Work @default.
• W2060273223 sameAs 2060273223 @default.
• W2060273223 citedByCount "26" @default.
• W2060273223 countsByYear W20602732232012 @default.
• W2060273223 countsByYear W20602732232013 @default.
• W2060273223 countsByYear W20602732232014 @default.
• W2060273223 countsByYear W20602732232017 @default.
• W2060273223 countsByYear W20602732232019 @default.
• W2060273223 countsByYear W20602732232021 @default.
• W2060273223 crossrefType "journal-article" @default.
• W2060273223 hasAuthorship W2060273223A5010130353 @default.
• W2060273223 hasAuthorship W2060273223A5032635453 @default.
• W2060273223 hasAuthorship W2060273223A5038762203 @default.
• W2060273223 hasAuthorship W2060273223A5049526464 @default.
• W2060273223 hasAuthorship W2060273223A5054566593 @default.
• W2060273223 hasAuthorship W2060273223A5057657554 @default.
• W2060273223 hasAuthorship W2060273223A5071257048 @default.
• W2060273223 hasConcept C104317684 @default.
• W2060273223 hasConcept C142724271 @default.
• W2060273223 hasConcept C2776577112 @default.
• W2060273223 hasConcept C2776715637 @default.
• W2060273223 hasConcept C2778256501 @default.
• W2060273223 hasConcept C2779672484 @default.
• W2060273223 hasConcept C2780844630 @default.
• W2060273223 hasConcept C30481170 @default.
• W2060273223 hasConcept C54355233 @default.
• W2060273223 hasConcept C55493867 @default.
• W2060273223 hasConcept C71924100 @default.
• W2060273223 hasConcept C81885089 @default.
• W2060273223 hasConcept C86803240 @default.
• W2060273223 hasConceptScore W2060273223C104317684 @default.
• W2060273223 hasConceptScore W2060273223C142724271 @default.
• W2060273223 hasConceptScore W2060273223C2776577112 @default.
• W2060273223 hasConceptScore W2060273223C2776715637 @default.
• W2060273223 hasConceptScore W2060273223C2778256501 @default.
• W2060273223 hasConceptScore W2060273223C2779672484 @default.
• W2060273223 hasConceptScore W2060273223C2780844630 @default.
• W2060273223 hasConceptScore W2060273223C30481170 @default.
• W2060273223 hasConceptScore W2060273223C54355233 @default.
• W2060273223 hasConceptScore W2060273223C55493867 @default.
• W2060273223 hasConceptScore W2060273223C71924100 @default.
• W2060273223 hasConceptScore W2060273223C81885089 @default.
• W2060273223 hasConceptScore W2060273223C86803240 @default.
• W2060273223 hasIssue "4" @default.
• W2060273223 hasLocation W20602732231 @default.
• W2060273223 hasLocation W20602732232 @default.
• W2060273223 hasOpenAccess W2060273223 @default.
• W2060273223 hasPrimaryLocation W20602732231 @default.
• W2060273223 hasRelatedWork W1712810897 @default.
• W2060273223 hasRelatedWork W1982602011 @default.
• W2060273223 hasRelatedWork W2011525561 @default.
• W2060273223 hasRelatedWork W2021113677 @default.
• W2060273223 hasRelatedWork W2137129233 @default.
• W2060273223 hasRelatedWork W2138805078 @default.
• W2060273223 hasRelatedWork W2414344877 @default.
• W2060273223 hasRelatedWork W2416630760 @default.
• W2060273223 hasRelatedWork W2523222294 @default.
• W2060273223 hasRelatedWork W324683605 @default.

• next